Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...
Novo Nordisk A/S’s Wegovy helped treat an obesity-associated liver disease in a late-stage trial, potentially adding to its ...
A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.
Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...
Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...
Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss ...
Novo Nordisk’s Wegovy helped people with a fatty liver disease called MASH experience improvements in liver scarring and achieve symptom resolution, new data show.
On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from part 1 of the ongoing ESSENCE Phase 3 trial, a 240-week ...
A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...